Description
Overview
Aromatase inhibitor for breast cancer.
Product Details
LETROZOLE 2.5 mg is used as adjuvant treatment for hormone receptor-positive breast cancer in postmenopausal women. It lowers estrogen production by inhibiting the aromatase enzyme, slowing tumor growth.
Key Benefits
- Clinically used and widely prescribed
- Supports effective symptom management
- Quality-controlled pharmaceutical product
How to Use
Use this medication exactly as prescribed by your healthcare provider. Dosage and duration depend on your condition and response to treatment.
Important Information
- Prescription may be required
- Consult your doctor before use
- Read the patient leaflet for full safety information
Reviews
There are no reviews yet.